GLP-1 Pregnancy Safety: Semaglutide and Tirzepatide
You are pregnant or planning to become pregnant. You are on a GLP-1 medication, or you are thinking about starting one and wondering whether pregnancy is possible while on the medication. The question is urgent and understandably confusing. The simple answer: GLP-1 medications are not recommended during pregnancy. If you are planning to conceive, you will need to stop the medication ahead of time.
This page covers what the FDA label says, what we know and do not know from human data, what happens if you become pregnant while taking GLP-1, and practical guidance for women of childbearing age who are considering these medications.
What the FDA Label Says
Both semaglutide and tirzepatide carry a pregnancy warning in the FDA-approved branded labeling.[1][2] The warning recommends stopping the medication at least 2 months before planned conception.
The 2-month window exists because these medications have a relatively long half-life.[1][2] They do not leave your body immediately after you stop taking them. Full systemic clearance takes time, and the FDA’s recommendation aims to create a buffer period so the medication is completely out of your system before conception occurs.
This is not a suggestion or a guideline that applies only to certain patients. It is an FDA label requirement that your provider should discuss with you if you are a woman of childbearing age and considering GLP-1 treatment.
Why Are These Medications Not Recommended in Pregnancy?
Three things inform the FDA’s warning: animal reproduction data, the newness of these medications in human use, and the theoretical risk of off-target effects during a critical window of fetal development.
Animal Reproduction Studies
In studies conducted before semaglutide and tirzepatide were approved for human use, pregnant animals given these medications showed adverse effects on embryo and fetal development.[1][2] These effects occurred at doses that were clinically relevant, meaning the doses used in animals were comparable to the doses used in human patients.
This is important context: Animal reproduction data does not always predict what will happen in humans. But it is the main evidence we have, and it is the basis for the pregnancy warning on both drugs’ labels.
Limited Human Data
GLP-1 medications, particularly semaglutide and tirzepatide, are relatively new.[1][2] The FDA-approved branded versions of semaglutide were authorized for diabetes in 2017 and for weight management in 2021, and the branded versions of tirzepatide much more recently. These medications have not been studied in large, prospective randomized trials of pregnant women, nor would they be for ethical reasons.
What we do have are case reports and registry data collected as providers and patients report outcomes. A small but growing body of real-world data is being compiled as more women conceive or become pregnant while on GLP-1 medications. But the evidence base remains limited compared to other medication classes with decades of pregnancy registry data.
Critical Window of Development
The 2-month clearance window is also designed to protect against fetal exposure during the very early weeks of pregnancy, when major organ systems are being formed. If you conceive soon after stopping a GLP-1 medication, the medication may still be present in your bloodstream at very low levels during this critical period. The 2-month recommendation aims to avoid that overlap entirely.
What Happens if You Become Pregnant While on GLP-1?
This is a real scenario because unplanned pregnancy is common, and women on GLP-1 may not immediately realize they are pregnant if they have irregular cycles (which can improve with GLP-1 treatment).
If you find out you are pregnant while taking a GLP-1 medication:
Contact your prescribing provider immediately. Do not wait for a scheduled appointment. Call and explain that you have just discovered you are pregnant and are currently on a GLP-1 medication. Your provider needs to know this right away.
Tell your OB/GYN as well. Your OB/GYN should be aware that you were taking a GLP-1 medication before you became aware of the pregnancy.
In most cases, your provider will discontinue the medication. Your provider will then assess your specific situation, including:
- How long you were on the medication before you found out you were pregnant
- At what stage of pregnancy you are now
- Whether you had any unplanned dose timing (for example, did you take your weekly injection after conception occurred)
- Your individual medical history
Early discovery of pregnancy while on GLP-1 is a different scenario than ongoing intentional use throughout pregnancy. Your provider will evaluate the specifics of your situation and discuss what monitoring, if any, may be appropriate.
The key is: Do not continue taking GLP-1 medication during pregnancy without explicit direction from your care team. If you discover you are pregnant, your first step is to contact your provider.
A Critical Point for Women with PCOS
If you have PCOS (polycystic ovary syndrome), this next part is especially important for you.
One of the reasons many women start GLP-1 medications is metabolic benefit. GLP-1 medications improve insulin sensitivity and reduce insulin resistance, which are core problems in PCOS.[3] As insulin resistance improves and weight comes down, ovulatory function often improves. This is genuinely good news for fertility. Many women with PCOS who had irregular cycles or believed they had low fertility risk see their cycles become more regular.
But here is the practical consequence: A woman who started GLP-1 thinking “I have PCOS and cannot easily get pregnant” may become pregnant unexpectedly while on the medication, before she intended to stop it.
If you have PCOS and are considering GLP-1 treatment, you need to think about contraception separately from the medication decision. Effective, reliable contraception is essential if you are not actively trying to conceive. Even if you have a history of irregular cycles or fertility challenges, GLP-1 treatment can shift your fertility status. Your provider can discuss which contraceptive option works best for you while you are on GLP-1.
GLP-1 and Oral Contraceptive Absorption
If you are using oral birth control pills for contraception, there is another layer to this conversation: GLP-1 medications slow gastric emptying,[1][2] meaning food (and medication) moves more slowly through your stomach. This delayed emptying can affect how well your body absorbs oral contraceptive pills.
The result is that the effectiveness of birth control pills may be reduced while you are on a GLP-1 medication. You should discuss this with your provider, particularly:
- If you are just starting a GLP-1 medication and are relying on oral contraception
- If you increase your dose of GLP-1 medication
Your provider may recommend backup contraception (for example, condoms) during the first 4 weeks after starting or increasing your GLP-1 dose, to ensure you are protected while your body is adjusting. Or your provider may recommend a different form of contraception altogether, such as an IUD or implant, which is not affected by GLP-1 medications.
The point is: Do not assume your birth control pills are equally effective while on GLP-1. Have that conversation with your provider.
Pregnancy Planning: A Timeline
If you are thinking about becoming pregnant in the next 6 to 12 months, here is a realistic timeline to discuss with your provider:
Months 1-2: You and your provider discuss your pregnancy timeline and your GLP-1 treatment. If you are considering GLP-1 and want to become pregnant soon, the medication may not be the right choice. If you are already on GLP-1 and want to conceive in the next 3-4 months, your provider may discuss starting to taper the medication now so it clears your system by the time you start trying.
Months 3-4: If you are stopping GLP-1 to prepare for conception, the medication is clearing your system during this window. Your provider may discuss nutrition and exercise planning during this time to maintain weight loss and healthy habits while you are not on medication.
Months 5+: You can begin trying to conceive. Your body has had time to fully clear the medication, and you and your provider can focus on other aspects of reproductive health, such as prenatal vitamins (including folic acid, which is critical for neural tube closure in early pregnancy).
The exact timeline depends on your provider’s assessment and your specific health situation. But the key is: Do not stop GLP-1 medication and immediately try to conceive. Build in the recommended 2-month clearance period first.
What Happens After Delivery
This question comes up often: “Can I get back on GLP-1 after my baby is born?”
The answer is yes, but with important considerations.
If you are breastfeeding: GLP-1 medications are not recommended during breastfeeding. There is insufficient data on how much semaglutide or tirzepatide passes into breast milk, and the medications have not been studied in nursing mothers. If you plan to breastfeed, you should wait to restart GLP-1 until you are done nursing.
If you are not breastfeeding: You can discuss restarting GLP-1 with your provider after delivery. Your provider will consider factors such as:
- Your physical recovery from pregnancy and delivery
- Your current health status and any postpartum complications
- Whether you are getting adequate nutrition if you are still recovering
- Your postpartum mood and mental health
Pregnancy and the postpartum period involve significant hormonal and physical changes. Your provider may recommend waiting a few weeks or months before restarting medication, to let your body stabilize and to allow adequate time for nutrition and recovery.
The conversation should happen during your postpartum visit. Plan to bring this up with your OB/GYN so that you and your care team can coordinate.
Medication Management and Informed Decision-Making
GLP-1 medications are clinical tools used for metabolic health and weight management. But they require informed decision-making, particularly if you are a woman who might become pregnant.
Here is what you need to know before starting a GLP-1 medication:
- GLP-1 medications are not recommended during pregnancy and should be stopped at least 2 months before conception
- If you are planning to become pregnant in the next 3-6 months, GLP-1 may not be right for you at this time
- If you are not planning pregnancy but are having unprotected sex or using unreliable contraception, discuss effective contraception with your provider before starting GLP-1
- If you are on oral contraceptive pills, discuss how GLP-1 affects pill effectiveness
- If you become pregnant while on GLP-1, contact your provider and OB/GYN immediately
- If you have PCOS, understand that improved fertility may come sooner than you expect, and plan contraception accordingly
A licensed provider should discuss all of these points with you during your intake evaluation. If your provider does not bring these up, you should.
Practical Next Steps
If you are pregnant or planning pregnancy and you are currently on or considering a GLP-1 medication, here is what to do:
Schedule a conversation with your prescribing provider about your pregnancy plans or current pregnancy. Be direct about the timeline.
If you are pregnant right now: Contact your provider today, inform your OB/GYN, and get guidance on stopping your medication safely.
If you are planning pregnancy in the next 3-6 months: Discuss whether GLP-1 is the right choice for you at this time, or whether stopping the medication and timing your conception is a better plan.
If you are not planning pregnancy but could become pregnant: Discuss contraception options that work well with GLP-1 treatment. Do not rely on oral contraceptive pills alone.
Get a full medical evaluation: An independent, licensed provider should review your complete health history and discuss whether GLP-1 is appropriate for you, given your current situation and reproductive plans.
Citations
[1] FDA. “Prescribing Information for semaglutide for chronic weight management.” Center for Drug Evaluation and Research. 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf
[2] FDA. “Prescribing Information for tirzepatide for type 2 diabetes.” Center for Drug Evaluation and Research. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
[3] Han Y, Li Y, He B. “GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis.” Reproductive BioMedicine Online. 2019;39(2):332-342. https://pubmed.ncbi.nlm.nih.gov/31229399/
Important: This information is for educational purposes only and does not constitute medical advice. Consult an independent, licensed healthcare provider before starting, stopping, or changing any medication, including during pregnancy planning. Compounded medications are not FDA-approved products. They are prepared by US-based, state-licensed compounding pharmacies and have not been independently evaluated by the FDA for safety, efficacy, or quality. All prescriptions require evaluation by an independent, licensed healthcare provider. Not all patients will qualify. Results vary by individual.